Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
BioCryst Announces Mundipharma Receives Approval for Mundesine® in Japan
Tuesday, April 04, 2017BioCryst Pharmaceuticals Inc announced that Mundipharma has obtained regulatory approval of Mundesine Forodesine hydrochloride for the treatment of relapsedrefractory PTCL Peripheral TCell Lymphoma by the Ministry of Health Labor and Welfare in Japan...
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
Tuesday, April 04, 2017Ipsen announced that it has completed its acquisition of global oncology assets from Merrimack Pharmaceuticals in Cambridge MA focusing on ONIVYDE irinotecan liposome injection for the treatment of patients with metastatic adenocarcinoma of the pancr...
Puma Biotechnology Launches Expanded Access Program for PB272 (Neratinib)
Monday, April 03, 2017Puma Biotechnology Inc a biopharmaceutical company has initiated an expanded access program EAP in the United States to provide its investigational therapy PB neratinib to patients with HERpositive breast cancer or HERmutated cancers The program will...
Astellas to Acquire Ogeda SA
Monday, April 03, 2017Astellas Pharma Inc and Ogeda SA announced that Astellas and Ogeda shareholders have entered into a definitive agreement under which Astellas has agreed to acquire Ogeda a privately owned drug discovery company Ogeda is a clinicalstage drug discovery...
Biogen wins Tecfidera U.S. patent dispute with Forward Pharma
Saturday, April 01, 2017A US patent board on Friday ruled against Danish drugmaker Forward Pharma AS finding Biogens patents on its blockbuster multiple sclerosis drug Tecfidera to be valid The ruling by the US Patent Trial and Appeal Board PTAP frees Bigoen Inc from fut...
miRagen Therapeutics Receives Orphan-Drug Designation for MRG-106
Saturday, April 01, 2017miRagen Therapeutics Inc a clinicalstage biopharmaceutical company focused on the discovery and development of microRNAtargeted therapies today announced that the US Food and Drug Administration FDA has granted orphandrug designation to miRagens prod...
Avillion Signs Clinical Co-development Agreement With Merck to Advance Anti IL-17 A/F Nanobody® in Psoriasis
Friday, March 31, 2017Avillion LLP a codeveloper and financier of latestage pharmaceutical product candidates announces that it has signed a clinical codevelopment agreement with Merck Darmstadt Germany a leading science and technology company to advance Mercks anti IL AF...
Hilleman Laboratories Signs MoU With NICED, ICMR to Develop Shigella Vaccine
Friday, March 31, 2017Hilleman Laboratories a jointventure partnership between MSD and Wellcome Trust signed a Memorandum of Understanding MoU with National Institute of Cholera and Enteric Diseases NICED an ICMR organization for further development and commercialization...
Espero Pharmaceuticals and Armetheon to Merge
Friday, March 31, 2017Espero Pharmaceuticals Inc a privately held commercialstage cardiovascular pharmaceutical company and Armetheon Inc a privately held lateclinical stage pharmaceutical company developing innovative novel drugs addressing major unmet needs in cardiovas...
Sonoma Pharmaceuticals Receives U.S. FDA Clearance of Loyon® Skin Descaler
Thursday, March 30, 2017Sonoma Pharmaceuticals Inc a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care today announced it has received a new k clearance from the...
